Skip to Main Content
Legislation Search

S. 3607: Access to Genetic Counselor Services Act of 2026

This bill, known as the Access to Genetic Counselor Services Act of 2026, aims to amend the Social Security Act to expand Medicare coverage for genetic counseling services. Here are the main points of the bill:

Overview of Genetic Counseling Services

Genetic counseling involves providing individuals and families with information and support regarding genetic conditions, including how genetic factors can affect health. This bill seeks to ensure that Medicare beneficiaries have better access to these services.

Changes to Medicare Coverage

The bill introduces several key amendments regarding the coverage of genetic counseling services under Medicare, effective starting January 1, 2027:

  • Included Services: Genetic counseling services will be officially defined as covered services under Medicare.
  • Provider Qualifications: Genetic counselors must either hold a license in the state where they practice or be certified by the American Board of Genetic Counseling if the state does not license genetic counselors.
  • Payment Structure: Medicare will reimburse genetic counseling services at 80% of the lesser of the actual charge or 85% of the standard physician fee schedule. This ensures that genetic counselors are compensated similarly to other healthcare providers.

Impact on Billing Practices

The bill addresses how genetic counselors can bill for their services under Medicare:

  • Balance Billing: The bill specifies that genetic counselors will be recognized for billing under existing balance billing provisions, allowing them to charge Medicare beneficiaries directly if necessary.
  • Other Providers: The changes will not prevent other healthcare providers, including physicians, from continuing to bill for genetic counseling services that are covered by Medicare.

Implementation and Administrative Authority

The Secretary of Health and Human Services is given the authority to implement these changes through interim final rules, allowing for quicker enactment of the new coverage provisions.

Conclusion on Coverage Inclusion

Overall, the bill aims to enhance Medicare's coverage of genetic counseling services, making it easier for beneficiaries to receive important genetic information and support.

Relevant Companies

  • ILMN (Illumina, Inc.) - Illumina is known for its genetic sequencing technology. Increased coverage of genetic counseling services could lead to higher demand for genetic testing products.
  • EXAS (Exact Sciences Corporation) - This company provides cancer screening and diagnostic products. Expanding genetic counseling could drive greater usage of their tests and services.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

4 bill sponsors

Actions

2 actions

Date Action
Jan. 08, 2026 Introduced in Senate
Jan. 08, 2026 Read twice and referred to the Committee on Finance. (text: CR S116-117)

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
Mar 09, 2026 Feb 10, 2026 +12.01%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN _ILLUMINA, INC CMN
Sale $1,001 - $15,000
Feb 06, 2026 Jan 29, 2026 -9.38%
Congress pfp
Lisa C. McClain R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $1,001 - $15,000
Nov 21, 2025 Oct 31, 2025 +6.94%
Congress pfp
Lisa C. McClain R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $1,001 - $15,000
Nov 21, 2025 Oct 30, 2025 +32.21%
Congress pfp
Lisa C. McClain R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
Nov 21, 2025 Oct 30, 2025 +32.21%
Congress pfp
Lisa C. McClain R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 13, 2025 Jun 09, 2025 +40.51%
Congress pfp
Thomas H. Kean, Jr. R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
Apr 18, 2025 Apr 01, 2025 +45.59%
Congress pfp
Thomas H. Kean, Jr. R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 15, 2025 Apr 01, 2025 +45.59%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN ILLUMINA, INC CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 25, 2025 +22.67%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $15,001 - $50,000
Sep 24, 2024 Sep 03, 2024 -21.01%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $15,001 - $50,000
Oct 01, 2024 Aug 30, 2024 -19.46%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN ILLUMINA, INC CMN
Sale $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 +1.21%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN ILLUMINA, INC CMN
Purchase $1,001 - $15,000
Jun 05, 2024 May 29, 2024 +0.51%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN ILLUMINA, INC CMN
Sale $1,001 - $15,000
Jun 05, 2024 May 28, 2024 -2.51%
Congress pfp
Josh Gottheimer D / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION - COMMON STOCK
Sale $1,001 - $15,000
Jun 08, 2024 May 10, 2024 +71.16%
Congress pfp
Thomas H. Kean, Jr. R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 30, 2024 Apr 19, 2024 -24.02%